clinical pearls: dermatology
TRANSCRIPT
![Page 1: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/1.jpg)
Clinical Pearls in Dermatology
Lisa H Scatena, M.D. F.A.A.D.Rocky Mountain Dermatology, Boulder
Assistant Clinical ProfessorDermatology & Internal Medicine
University of Colorado, Denver
6 February 2009
![Page 2: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/2.jpg)
What Can We Glean from the Largest Organ in the Body?
![Page 3: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/3.jpg)
What Can We Glean from the Largest Organ in the Body?
Earlier detection, diagnosis and treatment of systemic diseases.
![Page 4: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/4.jpg)
Where Have We Been and Where Are We Going?
2006- The skin biopsy
2008- Common dermatoses
2009- Systemic diseases and skin findings
2010- ?
![Page 5: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/5.jpg)
Learning Objectives Recognize newly described skin diseases
Review newer skin signs of well-established systemic diseases
Based upon skin findings, make appropriate diagnostic and therapeutic decisions for systemic diseases
![Page 7: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/7.jpg)
Case 1: A 54 year old man with diabetes mellitus and chronic renal failure complains of swelling, tightness and darkening of the skin on
his arms and legs. His symptoms have developed over the past 2-3 weeks following a
failed kidney transplant and imaging. Upon further questioning, this patient is most likely to
also complain of:
![Page 8: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/8.jpg)
Case 1: Upon further questioning, this patient is most likely to also complain of:
1. Burning and itching in his arms and legs
2. Changes in his vision3. Colicky abdominal pain4. Difficulty swallowing5. Oral ulcers
![Page 9: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/9.jpg)
Nephrogenic Fibrosing Dermopathy 15 patients with renal disease Extensive thickening and hardening of the skin
with brawny hyperpigmentation Nearly all had extremity lesions, tendency to
spare the trunk Some had diffuse thickening, others papules or
subcutaneous nodules
Cowper et al. Lancet 2000; 356:1000
![Page 10: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/10.jpg)
![Page 11: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/11.jpg)
![Page 12: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/12.jpg)
CD 34
![Page 13: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/13.jpg)
![Page 14: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/14.jpg)
Nephrogenic Fibrosing Dermopathy
Fibrosis may lead to calcification and dermal ossification
Extension from skin and subcutaneous tissue into the underlying fascia and muscle
Flexion contractures continue to worsen with resultant severe disablility
Increased mortality
![Page 15: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/15.jpg)
Nephrogenic Fibrosing Dermopathy
![Page 16: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/16.jpg)
Nephrogenic Fibrosing Dermopathy
The dominant cell is a dual staining CD34-procollagen fibrocyte corresponding to a circulating cell that expresses markers of both connective tissue cells and leukocytes
Aberrant fibrocyte recruitment, activation or proliferation the cause? Possibly related to ischemia
Curr Opin Rheumatol 2003, 15: 785
![Page 17: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/17.jpg)
CD 34
![Page 18: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/18.jpg)
Nephrogenic Fibrosing Dermopathy 33 patients in St Louis with NFD
Most had received dialysis Only 1 patient had not been exposed to gadolinium 4/33 had NOT been exposed to gadolinium for more
than a year (range: 16-68 months)
Gadolinium exposure has some causative role in NFD.
CDC NFD associated with exposure to gadolinium-containing contrast agents-St Louis, Missouri, 2002-2006. MMWR 2007 Feb 23;56;137-41
![Page 19: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/19.jpg)
Nephrogenic Fibrosing Dermopathy Cross sectional study of 186 dialysis patients in
Boston 25/186 had NFD skin changes identified (13%) 94% had exposure to Gadolinium Mortality rate among dialysis patients with NFD was
statistically greater than “usual” dialysis patients
NFD is a predictor of early mortality.
Todd et all. Cutaneous changes of NSF. Predictor of early mortality and associated with gadolinium exposure. Arth Rheum 2007 Sept 28;56:3433.
![Page 20: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/20.jpg)
![Page 21: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/21.jpg)
Nephrogenic Fibrosing Dermopathy
Topical steroids, retinoids, and lactic acid, systemic retinoids, and electron beam all tried without effect
Individual patients have responded to prednisone,plasmapheresis, IVIG, thalidomide, UV-A1, extracoporeal photopheresis and interferon-alpha, many others have not
Improvement of renal function or transplantation may improve NFD, but not always
Current favored therapy is PREVENTION
BJD 2005; 152: 531
![Page 22: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/22.jpg)
PEARL #1Consider alternate imaging processes when possible in patients with renal failure. If a patient must have an MRI, prompt dialysis
after MRI is suggested.
![Page 23: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/23.jpg)
![Page 24: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/24.jpg)
This 63 year old man has been on this medication for years. Not only has he experienced the skin changes below, he has developed arthralgias and a (+) ANCA.
![Page 25: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/25.jpg)
Causative agents for his skin changes include:
1. Amiodarone2. Gold3. Minocycline4. Plaquenil
![Page 26: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/26.jpg)
Minocycline Well known agent to
result in hyperpigmentation as a result of both melanin and iron deposition
Locations Blue-black scars Blue gray legs &
forearms Muddy brown on sun
exposed areas
Reported to cause a lupus-like syndrome
(+) ANA, (+) pANCA Occurs at a greater
rate in those patients on minocycline for longer duration of time
Resolves when minocyline is discontinued
![Page 27: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/27.jpg)
PEARL #2If a positive ROS is elicited for connective tissue disease in minocycline recipients,
consider serologic testing including ANCA.
![Page 28: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/28.jpg)
Case 3: Looking at What We Know from A Different Vantage Point…
![Page 29: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/29.jpg)
Courtesy of Dr. William James
![Page 30: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/30.jpg)
Case 3: A 56 year old woman with arthralgias, malaise, scaling scalp, and intractable itching develops this bizarre eruption. What other findings would you expect on examination?
1. Deep red-violaceous patches on extensor forearms
2. Lichenified, excoriated plaques periumbilical area
3. Scarring alopecia4. Violaceous tender nodules on shins
![Page 31: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/31.jpg)
Arch Dermatol 2000; 136: 665 J Rheum 1999;26:692
DermatomyositisCentripetal Flagellete Erythema
Edematous, erythematous streaks on the trunk and proximal extremities
Histology – interface dermatitis, positive direct immunofluorescence
Parallels disease activity Only reported in dermatomyositis, not seen in
other connective tissue diseases, in a review of 183 patients from one institution
Arch Dermatol 2000; 136: 665J Rheumatol 1999; 26: 692
![Page 32: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/32.jpg)
![Page 33: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/33.jpg)
![Page 34: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/34.jpg)
Dermatomyositis
![Page 35: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/35.jpg)
![Page 36: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/36.jpg)
Dermatomyositis: Gingival Telangiectases
Five patients with juvenile DM 1 boy, 4 girls All had similar nail fold telangiectases Other oral findings of DM include edema,
erosions, ulcers and white plaques
Arch Dermatol 1999; 135: 1370
![Page 37: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/37.jpg)
What finding is most predictive of an underlying malignancy in DM?1. Cutaneous
Necrosis2. Gottron Papules3. Itching4. Mechanics Hands5. Shawl sign
![Page 38: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/38.jpg)
![Page 39: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/39.jpg)
DermatomyositisCutaneous Necrosis
Cutaneous necrosis – rare in adults
1990: 5 cases reported in a study of 32 patients with dermatomyositis In 4 of 5 cases, patients had associated malignancy
7 of 10 in a larger series had malignancy
Positive predictive value of cutaneous necrosis is 71.4%
Cause uncertain, some with antiphospolipid antibodiesArch Dermatol 2003; 139: 539
![Page 40: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/40.jpg)
DermatomyositisRisk of Internal Malignancy
Classic dermatomyositis has a definite association with occult malignancy <25%
Women: ovarian carcinoma Asian men: nasopharyngeal carcinoma
Negative risk factor: Interstitial lung disease
Little-to-no increase risk of malignancy in polymyositis
Lancet 2001; 357:85-86Br J Cancer 2001; 85:41-45
Curr Opin Rheumatol 2000; 12:498-500
![Page 41: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/41.jpg)
DermatomyositisWhat about cutaneous amyopathic DM?
Sontheimer reviewed world literature which reported a total of 300 cases 10% of these were associated with malignancy
Mayo Clinic 1976-1994 found 32/746 patients had cutaneous amyopathic dermatomyositis 25% found to have malignancy in 2-10 year follow-up All were women Lung CA, ovarian CA, breast CA, endometrial CA and
metastatic adenocarcinoma of unknown primary
Dermatol Clin 2002; 20:387-408
![Page 42: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/42.jpg)
DermatomyositisOccult Malignancy Work-up
Repeat malignancy surveillance measures every 6-12 months for the first 3-5 years following the diagnosis
After 5 years, the risk of malignancy returns to that of the general population for that age and sex
Dermatol Clin 2002; 20:387-408
![Page 43: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/43.jpg)
PEARL #3In the case of a new diagnosis of
dermatomyositis in an adult, at a bare minimum, age appropriate screening for
malignancy should be performed. Strongly consider imaging if clinically indicated.
![Page 44: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/44.jpg)
Case 6 month history of this minimally itchy eruption. Started with 1 red patch and spread after application of a prescription medication.
![Page 45: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/45.jpg)
What prescription medication did he put on his skin with this resultant rash?
1. Efudex2. Eucerin Calming
Lotion3. Neosporin ointment4. Retin-A cream5. Triamcinolone cream
![Page 46: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/46.jpg)
![Page 47: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/47.jpg)
Tinea Versicolor Not really a dermatophyte, caused by Malassezia
furfur or pityrosporum ovale As a yeast, considered normal follicular flora As hyphae, results in skin disease Common in summer months Treatment
Azoles,selenium sulfide lotions, Zinc pyrithione soap PO Azoles for difficult to treat cases
Ketoconazole 400mg doses repeated monthly Itraconazole 200mg qd x7days Fluconazole 400mg once monthly
![Page 48: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/48.jpg)
PEARL #4If there is scale, SCRAPE IT!!
![Page 49: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/49.jpg)
64 year old man presents with asymptomatic 1-2mm firm, white-flesh colored bumps all over his face since his 30’s.
5.
PMHx: HTN, history of pneumothorax Medications: Lisinopril, ASA Wears sunscreen routinely 5-10 blistering sunburns in his lifetime
![Page 50: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/50.jpg)
Our patient:
![Page 51: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/51.jpg)
![Page 52: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/52.jpg)
![Page 53: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/53.jpg)
![Page 54: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/54.jpg)
![Page 55: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/55.jpg)
Our patient and his family members are at risk for:1. Adenocarcinoma2. Anticardiolipin
Syndrome3. Basal Cell
Carcinomas4. Factor V Leiden
Deficiency5. Renal Cell
Carcinoma
![Page 56: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/56.jpg)
Birt-Hogg-Dube Syndrome
Multiple smooth skin colored to whitish papules Face 60-70% Neck 80% Upper trunk 90%
Oral fibromas 25% Acrochordons 30% Lipomas and collagenomas 15%
![Page 57: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/57.jpg)
Birt-Hogg-Dube SyndromeAssociated Abnormalities
Skin papules develop in 30’s Pulmonary cysts and pneumothorax, symptoms
begin in late teens or 20s, odds ratio 50.3 Renal cancers, onset in 50s, 10% of hereditary
renal cancer patients with BHD, odds ratio 6.9, abdominal CT and renal ultrasound
Five patients with parotid oncocytomas
JAAD 2000; 43:1120
JAAD 2003; 48:111
![Page 58: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/58.jpg)
Birt-Hogg-Dube Syndrome
Described in 1977 as an autosomal dominant triad of skin findings fibrofolliculomas trichodiscomas acrochordons
Penetrance 88% over age 25, gene isolated on 17p, mutation in gene for protein folliculin
Understanding of cutaneous tumors, relationship to renal cancer and pulmonary cysts recently understood in the past five years
J Am Acad Dermatol 2003;49:698,717
![Page 59: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/59.jpg)
PEARL #5If you see a patient with numerous
monomorphic firm small papules on his face, ASK about family members. If others
in the family have similar bumps, this warrants further evaluation including skin
biopsy and renal imaging.
![Page 60: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/60.jpg)
Associated Disease?
![Page 61: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/61.jpg)
Associated disease?1. Deep fungal infection2. Diabetes Mellitus3. Hepatitis C Virus4. Lupus Erythematosus5. Sarcoidosis
![Page 62: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/62.jpg)
Necrobiosis Lipoidica Diabeticorum
![Page 63: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/63.jpg)
Necrobiosis Lipoidica Diabeticorum Women are over represented 3:1 to men <3% diabetics have NLD
80% DM diagnosis preceeds NLD 10% DM FOLLOWS NLD diagnosis
Chronic indolent course Complicated by ulceration (35%) Increased rate of microvascular disease in
this subset of diabetic patients
![Page 64: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/64.jpg)
PEARL #6If you see a patient with a waxy yellow atrophic plaque on the anterior tibia,
without a diagnosis of diabetes, check for it. If you see a patient with known diabetes
and NLD, aggressive management to minimize the risk of microvascular
complications is a must.
![Page 65: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/65.jpg)
38 yo IVDA, ETOH, HTN with tender plaques that began on his feet and hands.
![Page 66: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/66.jpg)
![Page 67: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/67.jpg)
Which of his pre-existing conditions has likely contributed to his dermatoses?
Alc
ohol
Coca
ine
use
Dia
betes
Mel
litus
Hyp
erte
nsion
IVDA
20% 20% 20%20%20%
10
1. Alcohol2. Cocaine use3. Diabetes Mellitus4. Hypertension5. IVDA
![Page 68: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/68.jpg)
Necrolytic Acral ErythemaHepatitis C
Ten patients, 4 reports 7 women, 3 men Ages 11-55 All hepatitis C positive
Arch Dermatol 2005; 141: 85
![Page 69: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/69.jpg)
Tender well-defined, velvety or scaly surfaced dusky red plaques
Occasional blisters and erosions Usually involves the dorsal feet, but legs
and hands also affected May respond to interferon, ribaviron, or
zinc treatment
Necrolytic Acral ErythemaHepatitis C
![Page 70: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/70.jpg)
PEARL #7A number of cutaneous clues can steer you towards Hepatitis C Virus Infection in the
appropriate patients.
![Page 71: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/71.jpg)
55yo man presents with an indolent onset of thick skin on the back of his neck and shoulders. He also complains of “chipmunk cheeks” which he did not have 6 months ago.
![Page 72: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/72.jpg)
Far and away, the most common association with his finding is:
Am
yloi
dosis
Der
mat
omyo
sitis
Dia
betes
Mel
litus
Hyp
othy
roid
ism
Sys
tem
ic L
upus
Er...
20% 20% 20%20%20%
10
1. Amyloidosis2. Dermatomyositis3. Diabetes Mellitus4. Hypothyroidism5. Systemic Lupus
Erythematosus
![Page 73: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/73.jpg)
Scleredema Characterized by stiffening and hardening of
subcutaneous tissues on face, neck, upper back, and chest
Variants Type 1:
Women primarily Following URI, especially GAS; may involve tongue,
pharnyx (self limiting <2y) Type 2:
No antecedent illness. MUGAS Type 3:
Middle-age men Associated with diabetes mellitus
![Page 74: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/74.jpg)
Scleredema Associated systemic symptoms can include:
Serositis, dysarthria, dysphagia, myositis, parotitis, ocular and cardiac abnormalities
DDx: Scleroderma, scleromyxedema, cellulitis
Treatment: Type 1: self limiting Type 2 and 3: PUVA, cyclophosphamide, corticosteroids
![Page 75: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/75.jpg)
PEARL #8Biopsy THICK skin
Consider fasting glucose, SPEP, UPEP, ASO titer
![Page 76: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/76.jpg)
58 year old man presents with painful genital sores and “thrush” in his mouth.
The thrush has not improved with nystatin swish and spit regimen. He recently got
new glasses, but he still finds his vision has changed and feels as if something is in his
eyes.He wonders if it could be from a lack of Vitamin D because his dermatologist has
beaten into him the need for daily sunscreen.
![Page 77: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/77.jpg)
![Page 78: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/78.jpg)
![Page 79: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/79.jpg)
![Page 80: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/80.jpg)
![Page 81: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/81.jpg)
Direct Immunofluorescence Study
IgG
![Page 82: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/82.jpg)
Your Leading Clinical Diagnosis is:
1. Cicatricial Pemphigoid
2. Herpes Simplex Virus
3. Major Apthous Ulcer Disease/Sutton’s Disease
4. Stevens Johnson Syndrome
5. Vitamin D Deficiency
![Page 83: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/83.jpg)
Anti-Epiligrin Cicatricial Pemphigoid
IgG
![Page 84: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/84.jpg)
Anti-Epiligrin Cicatricial Pemphigoid
Mucosal predominant blistering disease Mouth, eye and genital Skin involvement not uncommon
Pathogenic IgG antibodies against Laminin 5
Arch Dermatol 1994, 130:1521
![Page 85: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/85.jpg)
Cicatricial Pemphigoid
Immunologically distinct immunobullous dieases with scarring
Oral (90%), conjunctival (66%), Cutaneous lesions (25%)
Circulating autoantibodies targeting hemidesmosomal proteins: BP 180, BP 230 and integrins CP with antibodies directed against Laminin 5 or
epiligrin is associated with an increased risk for solid tumors, especially adenocarcinoma.
Vodegel RM, et al JAAD 2003;48:542.
![Page 86: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/86.jpg)
Anti-Laminin 5 Cicatricial Pemphigoid
Retrospective study of 35 patients, median age 65 10 had solitary solid tumors lung, stomach, colon, endometrial
Overall relative risk= 6.8; RR 1y after diagnosis = 15.4
8 of 10 developed cancer AFTER blisters 7 of 8, within 14 months of onset 8 of 8 died within 21 months of diagnosis
Lancet 2001; 357: 1850
![Page 87: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/87.jpg)
PEARL #8Wear your sunscreen. You wouldn’t want an
autoimmune blistering disorder AND a skin cancer.
![Page 88: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/88.jpg)
![Page 89: Clinical Pearls: Dermatology](https://reader034.vdocument.in/reader034/viewer/2022052316/559844bc1a28ab27328b484a/html5/thumbnails/89.jpg)